Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Count Me In (CMI) is launching its first patient-partnered research project translated entirely to Spanish.
The genetic variant frequently causes low white blood cell counts in African Americans who are otherwise healthy.
The fund will help to develop initiatives to support researchers of color and increase diversity in cancer research and patient care.
The Senate-passed bill memorializing Henrietta Lacks aims to address underrepresentation in cancer clinical trials.
The new collaboration will dig into tumor genome, microbiome to address colon cancer inequities among people of color.
With Stand Up To Cancer, he hopes to increase diversity in this field so all patients can benefit equally from potential cancer treatments.
The group of 15 medical students promotes medicine as a career choice for Black people.
The program’s home will be Callen-Lorde’s in-the-works site in downtown Brooklyn.
Medical students graded their institutions. Despite improvements, no school earned an A.
The study raises concerns about the effectiveness of cancer drugs, as genetic differences may affect how someone responds to a drug.
Can data from more than 1 million Americans accelerate research and medical breakthroughs that benefit everyone?
Hospitals must work harder to create more respectful and welcoming workplaces for the diverse resident physicians who train there.
Less than 5 percent of Black patients were involved in trials for 24 out of 31 cancer drugs approved since 2015.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.